ArticleLancet regional health. Americas2024

Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study.

María Eugenia Toledo-Romaní et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.